Menu Back toDay2-Session-4-A-Accelerating-Access-to-Health-Products
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Accelerating Access to Innovative Products – Improving Responses to Pandemic Diseases
Day2: Session 4-A: Accelerating Access to Health Products
Shun Jin, MBA
- Head, Regulatory Affairs, APMA
- Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore
D2:S4-A: 1.2: Overview of Early Access Regulatory Pathways for Innovation
- Associate Center Director (for New Drug Review)
- Pharmaceuticals and Medical Devices Agency (PMDA), Japan
D2:S4-A: 1.3: Overview of Early Access Regulatory Pathways for Innovation
- TFDA, Taiwan
D2:S4-A: 1.4: Perspective of Dengue Vaccine Registration Process
- Senior Regulatory Specialist, Health Products Regulation Grou
- Singapore HSA, Singapore